Merck KGaA ADR

Company Profile

Merck KGaA ADR had its IPO on under the ticker symbol MKKGY.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Merck KGaA ADR has a staff strength of 63,712 employees.

Stock update

Shares of Merck KGaA ADR opened at $35.33 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $35.3 - $35.67, and closed at $35.63.

This is a +0.74% increase from the previous day's closing price.

A total volume of 63,249 shares were traded at the close of the day’s session.

In the last one week, shares of Merck KGaA ADR have slipped by -1.17%.

Merck KGaA ADR's Key Ratios

Merck KGaA ADR has a market cap of $77.46 billion, indicating a price to book ratio of 2.7478 and a price to sales ratio of 3.8558.

In the last 12-months Merck KGaA ADR’s revenue was $22.06 billion with a gross profit of $13.74 billion and an EBITDA of $6.23 billion. The EBITDA ratio measures Merck KGaA ADR's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Merck KGaA ADR’s operating margin was 21.15% while its return on assets stood at 5.98% with a return of equity of 11.71%.

In Q2, Merck KGaA ADR’s quarterly earnings growth was a negative -18.6% while revenue growth was a negative 4.8%.

Merck KGaA ADR’s PE and PEG Ratio

Forward PE

16.3934

Trailing PE

23.4408

PEG

3.0657

Its diluted EPS in the last 12-months stands at $1.52 per share while it has a forward price to earnings multiple of 16.3934 and a PEG multiple of 3.0657. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Merck KGaA ADR’s profitability.

Merck KGaA ADR stock is trading at a EV to sales ratio of 4.2334 and a EV to EBITDA ratio of 14.0096. Its price to sales ratio in the trailing 12-months stood at 3.8558.

Merck KGaA ADR stock pays annual dividends of $2.2 per share, indicating a yield of 1.36% and a payout ratio of 23.6%.

Balance sheet and cash flow metrics

Total Assets

$48.78 billion

Total Liabilities

$8.85 billion

Operating Cash Flow

$0

Capital Expenditure

$327 million

Dividend Payout Ratio

23.6%

Merck KGaA ADR ended 2024 with $48.78 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $48.78 billion while shareholder equity stood at $26.70 billion.

Merck KGaA ADR ended 2024 with $0 in deferred long-term liabilities, $8.85 billion in other current liabilities, 565000000.00 in common stock, $19.76 billion in retained earnings and $18.10 billion in goodwill. Its cash balance stood at $1.76 billion and cash and short-term investments were $1.93 billion. The company’s total short-term debt was $1,690,000,000 while long-term debt stood at $0.

Merck KGaA ADR’s total current assets stands at $13.02 billion while long-term investments were $0 and short-term investments were $166.00 million. Its net receivables were $4.85 billion compared to accounts payable of $2.40 billion and inventory worth $5.00 billion.

In 2024, Merck KGaA ADR's operating cash flow was $0 while its capital expenditure stood at $327 million.

Comparatively, Merck KGaA ADR paid $0.24 in dividends in 2024.

Other key metrics

Current Trading Price

$35.63

52-Week High

$42.6797

52-Week Low

$30.1435

Analyst Target Price

$

Merck KGaA ADR stock is currently trading at $35.63 per share. It touched a 52-week high of $42.6797 and a 52-week low of $42.6797. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $34.67 and 200-day moving average was $36.43 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 5.2% are held by institutions.